Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 5, 2011, Pages 2076-2081

  Rosenbluth, Jennifer M ^a   Mays, Deborah J ^a   Jiang, Aixiang ^a   Shyr, Yu ^a   Pietenpol, Jennifer A ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

ChIP on chip; Consensus binding site; Muscle; p63; Stem cell

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; PROTEIN P73; RAPAMYCIN; UNTRANSLATED RNA;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL DIFFERENTIATION; GENE EXPRESSION; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RHABDOMYOSARCOMA;

CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENOME, HUMAN; HUMANS; MESODERM; MICRORNAS; NUCLEAR PROTEINS; PROTEIN BINDING; RHABDOMYOSARCOMA; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 79952129478     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1011936108     Document Type: Article

References (22)

1. Beckerman R, Prives C (2010) Transcriptional regulation by p53. Cold Spring Harb Perspect Biol 2:a000935.
2. Wei CL, et al. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219.
3. Smeenk L, et al. (2008) Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 36:3639-3654. (Pubitemid 351917528)
4. Murray-Zmijewski F, Lane DP, Bourdon JC (2006) p53/p63/p73 isoforms: An orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13:962-972.
5. Yang A, et al. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 24:593-602. (Pubitemid 350284225)
6. Rosenbluth JM, Mays DJ, Pino MF, Tang LJ, Pietenpol JA (2008) A gene signature-based approach identifies mTOR as a regulator of p73. Mol Cell Biol 28:5951-5964.
7. Ji X, Li W, Song J, Wei L, Liu XS (2006) CEAS: cis-regulatory element annotation system. Nucleic Acids Res 34(Web Server issue):W551-W554. (Pubitemid 44529830)
8. Perez CA, Ott J, Mays DJ, Pietenpol JA (2007) p63 consensus DNA-binding site: Identification, analysis and application into a p63MH algorithm. Oncogene 26:7363-7370. (Pubitemid 350115981)
9. Yang A, et al. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103. (Pubitemid 30143141)
10. Ostrovsky O, Bengal E, Aronheim A (2002) Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells. J Biol Chem 277:40043-40054. (Pubitemid 35190994)
11. Marson A, et al. (2008) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-533.
12. Cam H, et al. (2006) p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 10:281-293. (Pubitemid 44512191)
13. Petricoin EF, 3rd, et al. (2007) Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67:3431-3440.
14. Wachtel M, et al. (2004) Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64:5539-5545. (Pubitemid 39095545)
15. Charytonowicz E, Cordon-Cardo C, Matushansky I, Ziman M (2009) Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell? Cancer Lett 279:126-136.
16. Davicioni E, et al. (2006) Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66:6936-6946. (Pubitemid 44197668)
17. Mishra PJ, et al. (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68:4331-4339.
18. Chen JF, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233.
19. Subramanian S, et al. (2008) MicroRNA expression signature of human sarcomas. Oncogene 27:2015-2026. (Pubitemid 351442735)
20. Vilgelm A, El-Rifai W, Zaika A (2008) Therapeutic prospects for p73 and p63: Rising from the shadow of p53. Drug Resist Updat 11:152-163.
21. Yang A, et al. (2010) Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo. PLoS ONE 5:e11572.
22. Bell HS, Ryan KM (2007) Targeting the p53 family for cancer therapy: 'Big brother' joins the fight. Cell Cycle 6:1995-2000.